Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

fda.gov

1 of 0

Resource Description:

The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.

« Back to the HPV Types 16 and 18 Vaccine Cervarix Gets FDA Approval for Use in Girls and Young Women WisdomCard

Related Health Centers:

Retrieved from "http://www.organizedwisdom.com/Special:OW_Special_Nugget"

Advertisement

Health Centers

Wellness Centers

Living Centers